Drug intelligence / Profile preview

aminexil

Development stage
Unknown
Lead developer
L'Oréal
Modality
Small Molecules
Administration
Topical
01

Overview

Aminexil is a **small molecule** compound chemically known as diaminopyrimidine oxide and sometimes referred to as kopexil[3]. It is a topical agent primarily used for the treatment of hair loss, especially androgenetic alopecia. Unlike minoxidil (to which it is structurally related), aminexil's mechanism of action is believed to involve the inhibition of enzymes contributing to hair loss and improvement of hair anchoring. - It inhibits the activity and expression of lysyl oxidase, an enzyme involved in the thickening of the hair root sheath, thereby preventing perifollicular fibrosis—a process where rigid collagen pushes the hair root toward the surface, causing premature hair loss[6][5]. - It may also inhibit 5-alpha reductase, which converts testosterone to dihydrotestosterone (DHT), a hormone associated with follicular miniaturization and hair loss[1]. - Aminexil possibly improves scalp microcirculation, promoting nutrient delivery to hair follicles and healthier hair growth[1]. Developed and promoted by L'Oréal, aminexil is found in shampoos, serums, lotions, and other topical haircare products. Its efficacy is supported by clinical and anecdotal evidence, but it is not approved as a pharmaceutical drug in the US or Europe—it is regulated more as a cosmetic or dermocosmetic ingredient[3][6].

Brand names
AminexilDercos Aminexil Pro 5
Other names
diaminopyrimidine oxidekopexil
02

Targets

15-LOX (Lysyl Oxidase)

Beyond the preview

Go deeper on aminexil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on aminexil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call